Hypertensive Disorders of Pregnancy and Medication Use in the 2015 Pelotas (Brazil) Birth Cohort Study.

International Journal of Environmental Research and Public Health
Lisiane Freitas LealAndréa Dâmaso Bertoldi

Abstract

Hypertensive disorders of pregnancy account for approximately 22% of all maternal deaths in Latin America and the Caribbean. Pharmacotherapies play an important role in preventing and reducing the occurrence of adverse outcomes. However, the patterns of medications used for treating women with hypertensive disorders of pregnancy (HDP) living in this country is unclear. A population-based birth cohort study including 4262 women was conducted to describe the pattern of use of cardiovascular agents and acetylsalicylic acid between women with and without HDP in the 2015 Pelotas (Brazil) Birth Cohort. The prevalence of maternal and perinatal outcomes in this population was also assessed. HDP were classified according to Ministry of Health recommendations. Medications were defined using the Anatomical Therapeutic Chemical Classification System and the substance name. In this cohort, 1336 (31.3%) of women had HDP. Gestational hypertension was present in 636 (47.6%) women, 409 (30.6%) had chronic hypertension, 191 (14.3%) pre-eclampsia, and 89 (6.7%) pre-eclampsia superimposed on chronic hypertension. Approximately 70% of women with HDP reported not using any cardiovascular medications. Methyldopa in monotherapy was the most frequent t...Continue Reading

References

Sep 10, 2005·American Journal of Obstetrics and Gynecology·Martha M WerlerMargaret A Honein
Apr 26, 2006·Cadernos de saúde pública·Claudia Garcia Serpa Osorio-de-CastroMaria do Carmo Leal
Apr 7, 2010·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·Kwabena A Danso, Henry S Opare-Addo
Aug 25, 2010·Obstetrics and Gynecology·Peter von DadelszenUNKNOWN Translating Evidence-Based Surveillance and Treatment Strategies (TESS) Group
Feb 22, 2011·Best Practice & Research. Clinical Obstetrics & Gynaecology·Jennifer A HutcheonK S Joseph
Feb 26, 2011·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·Robert L GoldenbergAlan H Jobe
May 13, 2011·Lancet·Cesar G VictoraCelia L Szwarcwald
May 20, 2011·Best Practice & Research. Clinical Obstetrics & Gynaecology·Tabassum FirozPeter von Dadelszen
Mar 9, 2013·Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'obstétrique Et Gynécologie Du Canada : JOGC·Shifana LalaniUNKNOWN Community Level Interventions for Pre-eclampsia (CLIP) Working Group
Oct 12, 2013·Bulletin of the World Health Organization·Tabassum FirozUNKNOWN Maternal Morbidity Working Group
Mar 20, 2014·BJOG : an International Journal of Obstetrics and Gynaecology·E AbalosUNKNOWN WHO Multicountry Survey on Maternal and Newborn Health Research Network
Aug 12, 2014·The Lancet Global Health·Lale SayLeontine Alkema
Apr 1, 2014·Pregnancy Hypertension·Laura A MageeUNKNOWN Canadian Hypertensive Disorders of Pregnancy (HDP) Working Group
Sep 8, 2015·Lancet·Ben W J MolG Justus Hofmeyr
Dec 8, 2016·Obstetrics and Gynecology·Brian T BatemanKrista F Huybrechts
Nov 11, 2017·International Journal of Epidemiology·Pedro C HallalDiego G Bassani
Jun 26, 2018·International Journal of Epidemiology·Mariangela F SilveiraUNKNOWN Pelotas Cohorts Study Group
Jun 28, 2018·Reproductive Health·Robert L GoldenbergSarah Saleem
Oct 3, 2018·The Cochrane Database of Systematic Reviews·Edgardo AbalosCelina Gialdini
Nov 28, 2018·The Cochrane Database of Systematic Reviews·Philippa MiddletonMaria Makrides
Sep 11, 2019·BMJ : British Medical Journal·Katie WebsterUNKNOWN Guideline Committee
Nov 8, 2019·Obstetrics and Gynecology·Jing HaoSusan R Snyder
Nov 26, 2019·Obstetrics and Gynecology·Jing HaoSusan R Snyder
Feb 9, 2020·International Journal of Environmental Research and Public Health·Bárbara Heather LutzAndréa Dâmaso Bertoldi

❮ Previous
Next ❯

Methods Mentioned

BETA
pharmacotherapy

Software Mentioned

SAS
FEBRASGO

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.